BlockTower Capital's Chief Information Officer: The idea of the U.S. government holding strategic reserves of Bitcoin is beneficial to its price
Ari Paul, Chief Information Officer of BlockTower Capital, stated that the idea of the U.S. government holding a strategic reserve of Bitcoin could potentially be beneficial for its price, but it's unrealistic to actually implement in the short term. "I would bet 10:1 against the U.S. treating Bitcoin as a strategic reserve within the next four years," he said. That being said, I think Trump might say this and it would be very favorable for Bitcoin's medium-term trend," Paul further explained that while the next president might say they have no intention of selling any Bitcoins currently held by the government, this does not mean they are actually "establishing a strategic Bitcoin reserve."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
